# US 2016/0251707 A1 · Karyotyping assay

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251707 A1
- Document ID: US20160251707A1
- Status: Published application
- Kind: A1
- Application number: 15/057,443
- Filed: 2016-03-01
- Published: 2016-09-01
- Earliest claimed: 2010-05-14
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: Adam BROOMER; Kelly Li; Andreas Tobler; Caifu Chen; David Keys
- Web page: https://patentgrep.com/patent/US20160251707A1

## CPC

- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure relates to methods and kits for karyotyping in which chromosomes are interrogated by amplifying loci that are not within copy number variable regions thereof.

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

An array comprising a plurality of oligonucleotide probe sets, wherein each probe has a portion that is specific for at least one target locus in at least one chromosome, wherein the target locus is located on a region of the chromosome that is not within a copy number variable region on the chromosome.

### Claim 23 (depends on 22)

The array of claim 22, wherein the plurality of oligonucleotide probe sets are immobilized on a solid support.

### Claim 24 (depends on 22)

The array of claim 22, wherein the plurality of oligonucleotide probe sets comprise subsets of probes that are specific for at least two target loci outside of a CNVR from at least one chromosome.

### Claim 25 (depends on 22)

The array of claim 22, wherein the at least one chromosome is selected 5 from human chromosomes 1-22, X and Y.

### Claim 26 (depends on 22)

The array of claim 22, wherein the nucleic acid probes are selected from the group consisting of SEQ ID NO: 193-288.

### Claim 27 (depends on 22)

The array of claim 22, wherein the nucleic acid primers are selected from the group consisting of SEQ ID NO: 1-192.

### Claim at position 8

28-33. (canceled)

### Claim 34 (depends on 22)

Use of the array of claim 22 for diagnosing a disease resulting from a chromosomal abnormality.

### Claim 35 (depends on 28)

Use of the kit of claim 28 for diagnosing a disease resulting from a chromosomal abnormality.
